Area of research
Pathology and Forensic Medicine · Cancer Research
Research interest
Research interests include Cancer Mechanisms and Therapy, Cancer, Hypoxia, and Metabolism, RNA modifications and cancer, and Pancreatic and Hepatic Oncology Research.
DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma
Long non-coding RNA in glioma: novel genetic players in temozolomide resistance
MALAT1-regulated gene expression profiling in lung cancer cell lines
Succinyl-CoA ligase ADP-forming subunit beta promotes stress granule assembly to regulate redox and drive cancer metastasis
Mitochondrial glutamate transporter SLC25A22 uni-directionally export glutamate for metabolic rewiring in radioresistant glioblastoma
Targeting Glioblastoma Stem Cells to Overcome Chemoresistance: An Overview of Current Therapeutic Strategies
EGFR-phosphorylated GDH1 harmonizes with RSK2 to drive CREB activation and tumor metastasis in EGFR-activated lung cancer
The Involvement of Long Non-Coding RNAs in Glutamine-Metabolic Reprogramming and Therapeutic Resistance in Cancer
Cisplatin-mediated activation of glucocorticoid receptor induces platinum resistance via MAST1
DGKA Provides Platinum Resistance in Ovarian Cancer Through Activation of c-JUN–WEE1 Signaling
Hsp90B enhances MAST1-mediated cisplatin resistance by protecting MAST1 from proteosomal degradation
LDR-Induced miR-30a and miR-30b Target the PAI-1 Pathway to Control Adverse Effects of NSCLC Radiotherapy